mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
GSK429286A |
GDSC1000 |
pan-cancer |
AAC |
-0.016 |
0.6 |
mRNA |
Midostaurin |
GDSC1000 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
NSC23766 |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
GW-2580 |
GDSC1000 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
BRD-K27986637 |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.6 |
mRNA |
CIL55A |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.6 |
mRNA |
ciclosporin |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
lenvatinib |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |